KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Net Cash Flow (2016 - 2025)

Exact Sciences (EXAS) has disclosed Net Cash Flow for 16 consecutive years, with $166.9 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 963.95% to $166.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $348.5 million through Dec 2025, up 136554.51% year-over-year, with the annual reading at $348.5 million for FY2025, 136554.51% up from the prior year.
  • Net Cash Flow for Q4 2025 was $166.9 million at Exact Sciences, up from $131.9 million in the prior quarter.
  • The five-year high for Net Cash Flow was $309.4 million in Q2 2025, with the low at -$740.1 million in Q2 2021.
  • Average Net Cash Flow over 5 years is -$26.7 million, with a median of $19.9 million recorded in 2022.
  • The sharpest move saw Net Cash Flow plummeted 25851.15% in 2021, then skyrocketed 963.95% in 2025.
  • Over 5 years, Net Cash Flow stood at $41.7 million in 2021, then plummeted by 90.45% to $4.0 million in 2022, then soared by 222.0% to $12.8 million in 2023, then grew by 22.4% to $15.7 million in 2024, then surged by 963.95% to $166.9 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $166.9 million, $131.9 million, and $309.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.